인간 배아줄기세포 유래 심근세포의 약물 스크리닝 모델로의 활용에 관한 연구 동향

김윤영, 구승엽, 최영민 · 인구의학연구논집 · 2010

Human embryonic stem cells (hESCs) and -derivatives are promising cell sources due to their unique ability of differentiation into specific lineage in regenerative medicine. Recently, many pharmaceutical companies focused their attention on the potential of hESCs as screening models for development of new drugs. Pre-clinical model of drug screening is animal-based model, therefore, interpretation of responses to certain chemical is different from that of human. In this regards, human cell-based model is necessary and the hESCs and differentiated cells are valuable as screening platform. In this review, we highlighted the recent researches using hESC-derived cardiomyocytes (CMs) as drug screening model.

Cited by 0 works.

Authors